Tandem Diabetes Care Inc (TNDM): Next-Year EPS Estimate 121.15%
As of 2026-08-25, Tandem Diabetes Care Inc (TNDM) has a next-year EPS growth estimate of 121.15%. Featured in our EPS revision report on 2026-07-20.
On 2026-08-21, analyst consensus for TNDM's next-year EPS growth shifted from 121.61% to 121.15% — a negative change of 0.46 percentage points. The revised estimate has been sustained across 4 subsequent trading sessions. Current-year growth is projected at 54.02%.
What's Driving This
The primary structural driver is the upward revision to next-year EPS growth estimates, raised from 113.09% to 119.85% on 2026-07-16 and now at 121.15%, indicating continued momentum. The upgrade follows Tandem's Q2 2026 earnings call, and the announcement that it will file its tubeless insulin pump with the FDA this quarter likely reinforced expectations. These factors combined support the stock's rise.
Generated 2026-08-25 from news as of 2026-08-25
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 121.15%
- EPS growth this year
- 54.02%
- EPS next quarter (est)
- -$0.24
- Last price
- $21.58
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-25 | 121.15% | 54.02% | -$0.24 | $21.58 |
| 2026-08-24 | 121.15% | 54.02% | -$0.24 | $22.22 |
| 2026-08-23 | 121.15% | 54.02% | -$0.24 | $22.32 |
| 2026-08-21 | 121.15% | 54.02% | -$0.24 | $22.32 |
| 2026-08-20 | 121.61% | 54.07% | -$0.24 | $22.57 |
| 2026-08-19 | 121.61% | 54.07% | -$0.24 | $23.46 |
| 2026-08-18 | 121.61% | 54.07% | -$0.24 | $23.73 |
| 2026-08-17 | 121.61% | 54.07% | -$0.24 | $22.25 |
| 2026-08-16 | 123.61% | 54.17% | -$0.24 | $22.72 |
| 2026-08-14 | 123.61% | 54.17% | -$0.24 | $22.72 |
| 2026-08-13 | 123.61% | 54.17% | -$0.24 | $23.13 |
| 2026-08-12 | 123.61% | 54.17% | -$0.24 | $23.44 |
| 2026-08-11 | 123.59% | 54.16% | -$0.24 | $23.44 |
| 2026-08-10 | 123.59% | 54.16% | -$0.24 | $22.81 |
| 2026-08-09 | 122.11% | 53.41% | -$0.24 | $22.38 |
| 2026-08-07 | 122.11% | 53.41% | -$0.24 | $22.38 |
| 2026-08-06 | 118.87% | 53.89% | -$0.32 | $18.79 |
| 2026-08-05 | 118.87% | 53.89% | -$0.32 | $19.59 |
| 2026-08-04 | 118.87% | 53.89% | -$0.32 | $20.20 |
| 2026-08-03 | 118.87% | 53.89% | -$0.32 | $20.11 |
| 2026-08-02 | 118.87% | 53.89% | -$0.32 | $19.50 |
| 2026-07-31 | 118.87% | 53.89% | -$0.32 | $19.50 |
| 2026-07-30 | 118.87% | 53.89% | -$0.32 | $19.01 |
| 2026-07-29 | 118.87% | 53.89% | -$0.32 | $18.59 |
| 2026-07-28 | 118.87% | 53.89% | -$0.32 | $17.76 |
| 2026-07-27 | 119.84% | 53.46% | -$0.32 | $17.17 |
| 2026-07-26 | 119.84% | 53.46% | -$0.32 | $17.12 |
| 2026-07-24 | 119.84% | 53.46% | -$0.32 | $17.12 |
| 2026-07-23 | 119.84% | 53.46% | -$0.32 | $16.90 |
| 2026-07-22 | 119.84% | 53.47% | -$0.32 | $16.91 |
Reports Featuring TNDM
Recent News
Screen Performance
Aggregate stats across all 2014 tickers our top-EPS-revision screen has flagged over the past 146 days.
- Median return since detection
- +3.1%
- % of tickers in the green
- 56%
- Median return on winners
- +19.9%
- Large revisions captured
- 1606
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Tandem Diabetes Care Inc's next-year EPS growth estimate?▾
As of 2026-08-25, Tandem Diabetes Care Inc (TNDM) has a next-year EPS growth estimate of 121.15%, based on analyst consensus.
When was the latest EPS estimate revision for TNDM?▾
The most recent revision occurred on 2026-08-21, when analysts adjusted the next-year EPS growth estimate from 121.61% to 121.15%.
What sector and industry does Tandem Diabetes Care Inc belong to?▾
Tandem Diabetes Care Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TNDM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Tandem Diabetes Care Inc (TNDM) appears here because it was detected by our daily top-EPS-revision-performer screen.